World's Best Scientists 2026 revealed!
Hiddo J.L. Heerspink

Hiddo J.L. Heerspink

D-Index & Metrics

Medicine

D-Index
106
Citations
51283
World Ranking
6423
National Ranking
244

Overview

Hiddo J.L. Heerspink is affiliated with the University of Groningen in the Netherlands. Their research primarily spans the field of Medicine, with a specific focus on endocrinology, diabetes, metabolism, and nephrology. The breadth of their work covers 1,436 publications, with key subfields including Endocrinology, Diabetes and Metabolism (540 publications), Nephrology (284 publications), Surgery (154 publications), Cardiology and Cardiovascular Medicine (119 publications), and Molecular Biology (83 publications).

The scientist's work addresses several main topics, highlighting Diabetes Treatment and Management with 756 publications, along with Chronic Kidney Disease and Diabetes (346 publications), Pancreatic Function and Diabetes (246 publications), Diabetes Management and Research (182 publications), Metabolism, Diabetes, and Cancer (120 publications), Renal Diseases and Glomerulopathies (118 publications), and Hormonal Regulation and Hypertension (94 publications).

Hiddo J.L. Heerspink has authored numerous papers featured in notable medical and scientific journals. The most cited recent works include:

  • Dapagliflozin in Patients with Chronic Kidney Disease, 2020, New England Journal of Medicine
  • KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease, 2022, Kidney International
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials, 2022, The Lancet
  • Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial, 2020, The Lancet Diabetes & Endocrinology
  • SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications, 2021, The Lancet

Frequent collaborators in their research include Peter Rossing, David C. Wheeler, Vlado Perkovic, Dick de Zeeuw, and Brendon L. Neuen. These co-authors have many joint publications, indicating ongoing collaborative efforts in related research areas.

Hiddo J.L. Heerspink's work is regularly published in prominent venues such as the Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation, Diabetes Obesity and Metabolism, Kidney International Reports, and Diabetes. The count of publications in these journals reflects the sustained engagement in both nephrology and diabetes research fields.

Best Publications

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • Dapagliflozin in Patients with Chronic Kidney Disease

    Hiddo J.L. Heerspink;Bergur V. Stefánsson;Ricardo Correa-Rotter;Glenn M. Chertow

  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

    Ron T Gansevoort;Ricardo Correa-Rotter;Brenda R Hemmelgarn;Tazeen H Jafar

  • Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

    Caroline S. Fox;Kunihiro Matsushita;Mark Woodward;Mark Woodward;Henk J.G. Bilo

  • Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

    Hiddo J.L. Heerspink;Bruce A. Perkins;David H. Fitchett;Mansoor Husain

  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    Dick de Zeeuw;Tadao Akizawa;Paul Audhya;George L. Bakris

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    Adeera Levin;Marcello Tonelli;Joseph Bonventre;Josef Coresh

  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Ian H. de Boer;M. Luiza Caramori;Juliana C.N. Chan;Hiddo J.L. Heerspink

  • SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

    Brendon L Neuen;Tamara Young;Hiddo J L Heerspink;Hiddo J L Heerspink;Bruce Neal;Bruce Neal;Bruce Neal

  • Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment

    Lennart Tonneijck;Marcel H.A. Muskiet;Mark M. Smits;Erik J. van Bommel

  • Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

    Ofri Mosenzon;Stephen D Wiviott;Avivit Cahn;Aliza Rozenberg

  • Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

    Navdeep Tangri;Morgan E. Grams;Andrew S. Levey;Josef Coresh

  • Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

    Hiddo J Lambers Heerspink;Hiddo J Lambers Heerspink;Toshiharu Ninomiya;Sophia Zoungas;Sophia Zoungas;Dick de Zeeuw

  • Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

    Karani S Vimaleswaran;Karani S Vimaleswaran;Alana Cavadino;Diane J Berry;Rolf Jorde

  • Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

    Andrew S. Levey;Ron T. Gansevoort;Josef Coresh;Lesley A. Inker

  • Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

    David C Wheeler;David C Wheeler;Bergur V Stefánsson;Niels Jongs;Glenn M Chertow

  • Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

    Kevin Damman;Joost C Beusekamp;Eva M Boorsma;Henk P Swart

  • Intensive glucose control improves kidney outcomes in patients with type 2 diabetes

    Vlado Perkovic;Hiddo Lambers Heerspink;John P Chalmers;Mark Woodward;Mark Woodward

  • Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects

    Hiddo J. L. Heerspink;Mehul Desai;Meg Jardine;Dainius Balis

  • SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.

    Emily Brown;Hiddo J L Heerspink;Daniel J Cuthbertson;John P H Wilding

Frequent Co-Authors

Dick de Zeeuw
Dick de Zeeuw University of Groningen
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Bruce Neal
Bruce Neal George Institute for Global Health
Peter Rossing
Peter Rossing University of Copenhagen
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen
David C. Wheeler
David C. Wheeler University College London
Stephan J. L. Bakker
Stephan J. L. Bakker University Medical Center Groningen
Tom Greene
Tom Greene University of Utah
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Carol A. Pollock
Carol A. Pollock University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine or healthcare, online degrees offer unparalleled flexibility and accessibility. Many students start with rn to bsn programs, especially if you are already a registered nurse looking to advance your qualifications without extensive on-site clinicals.

For those interested in healthcare leadership and administration, consider the top online mha programs that are cahme accredited. These programs focus on essential management skills and are nationally recognized for their quality.

Aspiring nurse leaders and advanced practice professionals can explore dnp programs online. There are also options for online dnp programs without clinicals, making it easier to pursue a doctorate while balancing work and personal responsibilities.

These related online degrees offer multiple pathways into the medical field—whether you want to advance in nursing, move into administration, or reach the highest levels of clinical practice. Explore your options to find the program that fits your goals.

Best Scientists Citing Hiddo J.L. Heerspink

Trending Scientists

Recently Published Articles